SyntheticMR announced today that they have entered a development project together with Juntendo University Hospital, based in Tokyo, Japan, and Canon Medical Systems.
STOCKHOLM, June 9, 2021 /PRNewswire/ -- SyntheticMR announced today that they have entered a development project together with Juntendo University Hospital, based in Tokyo, Japan, and Canon Medical Systems. The project will focus on joint development and evaluation of quantitative MR imaging solutions for clinical practice. CONTACT: For additional information, please contact Ulrik Harrysson, CEO, SyntheticMR AB, +46 70 529 29 87 ulrik.harrysson@syntheticmr.com This information was brought to you by Cision http://news.cision.com The following files are available for download:
SOURCE Cision AB |
||||
Company Codes: ISIN:SE0015987946, Stockholm:SYNT |